Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist.
Int J Tissue React
; 8(6): 497-504, 1986.
Article
em En
| MEDLINE
| ID: mdl-3025124
ABSTRACT
The ECG and haemodynamic alterations caused by the i.v. infusion of platelet-activating factor (PAF) in the rabbit were studied after pretreatment with Kadsurenone, a specific PAF-receptor antagonist. Infusion of PAF at 0.8 microgram/kg in the rabbit caused important ECG changes, such as ST-segment depression and conduction arrhythmias, concomitantly with a marked reduction in left ventricular systolic pressure, mean arterial pressure and cardiac output, with a rise in total peripheral resistances and mean right atrial pressure. These physiological parameters became maximal at 75-120 seconds after PAF challenge, and returned to near prechallenge values within 25-60 minutes. Pretreatment with Kadsurenone, administered either intravenously (0.014 M, 1 ml/kg) or intraperitoneally (0.14 M, 1 ml/kg), exerted a quite complete protective effect in regard to the ECG changes and caused a significant reduction in the magnitude of all the haemodynamic alterations observed after intravenous infusion of PAF (0.8 microgram/kg). These results suggest that Kadsurenone is an effective inhibitor of PAF-induced cardiovascular changes in the rabbit, probably due to its competitive antagonism against PAF binding to specific receptors.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Benzofuranos
/
Fator de Ativação de Plaquetas
/
Glicoproteínas da Membrana de Plaquetas
/
Sistema Cardiovascular
/
Lignanas
/
Receptores de Superfície Celular
/
Receptores Acoplados a Proteínas G
Limite:
Animals
Idioma:
En
Ano de publicação:
1986
Tipo de documento:
Article